Biorestorative Therapies, Inc. - Employees, Business, Industry & CEO


Biorestorative Therapies, Inc. Frequently Asked Questions

Where are Biorestorative Therapies, Inc. headquarters?

Biorestorative Therapies, Inc. headquarters are in 40 Marcus Drive, Suite One, Melville, New York 11747, US.

How many employees does Biorestorative Therapies, Inc. have?

Biorestorative Therapies, Inc. has 16 employees.

What sector does Biorestorative Therapies, Inc. operate in?

Biorestorative Therapies, Inc. is in Biotechnology Research sector.

What does Biorestorative Therapies, Inc. Do ?

BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders:• Disc/Spine Program (brtxDISC™): Our lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. We intend that the product will be used for the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The BRTX-100 production process involves collecting a patient’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have received clearance from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs.• Metabolic Program (ThermoStem®): We are developing a cell-based therapy to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (“BAT”). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

What does Biorestorative Therapies, Inc. specialize into ?

We are not able to find any specialities related to Biorestorative Therapies, Inc. at the moment.

Who is the CEO of Biorestorative Therapies, Inc. ?

We do not have the information about the CEO of Biorestorative Therapies, Inc.. Our systems are trying to find it, we will update it as soon as we have it.

Biorestorative Therapies, Inc.- Phone & Email of Top Employees & Directors


Human Resources (HR)

HR Head and director

xxxx@biorestorative.com
98378*****
CEO

Chief Executive Officer

xxxx@biorestorative.com
98263*****
Founder and Cofounder

Founder

xxxx@biorestorative.com
98483*****
MD

Managing Director

xxxx@biorestorative.com
98800*****
Finance

Finance Head and Director

xxxx@biorestorative.com
98375*****
Operations

Operations Head and Director

xxxx@biorestorative.com
98694*****
Information Technology (IT)

IT Head and Director

xxxx@biorestorative.com
98250*****
Sales

Sales Head and Director

xxxx@biorestorative.com
98928*****
Marketing

Marketing Head and Director

xxxx@biorestorative.com
98199*****
Purchase and Procurement

Purchase Head and Director

xxxx@biorestorative.com
98580*****
Admin

Admin Head and Director

xxxx@biorestorative.com
98566*****
Legal

Legal Head and Director

xxxx@biorestorative.com
98978*****
CSR

CSR Head and Director

xxxx@biorestorative.com
98327*****

The most accurate data ever

GDPR Compliant
150M Personal Emails
200M Work Emails
100M Direct Dials
250M Professional Profiles
30M Company Profiles